Skip to content


Ziagen (abacavir) is a small molecule pharmaceutical. Abacavir was first approved as Ziagen on 1998-12-17. It is used to treat acquired immunodeficiency syndrome and HIV infections in the USA. It has been approved in Europe to treat HIV infections. The pharmaceutical is active against Gag-Pol and Gag-Pol polyprotein.
Trade Name Ziagen
Common Name Abacavir
Indication acquired immunodeficiency syndrome, hiv infections
Drug Class Antivirals: carbocyclic nucleosides
Get full access now